GlassScriptPhysician profile
Bradley Medling
NPI 1265654636
$1,490.46
in general payments reported to CMS, 2019-2025
13 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $93.98 · 2021: $104 · 2022: $164 · 2023: $297 · 2024: $502 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Travel and Lodging: $14.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.78 |
| Travel and Lodging | $14.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $480.54 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $205.80 | 2023-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $183.39 | 2023-2025 | |
| Sientra, INC. | $152.93 | 2021-2022 | |
| Motiva USA, LLC | $130.94 | 2024-2025 | |
| Tela Bio, INC. | $107.77 | 2021-2024 | Ovitex 2s |
| Abbvie INC. | $77.05 | 2024-2025 | |
| Janssen Biotech, INC. | $41.65 | 2023-2024 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.87 | 2020-2022 | |
| Incyte Corporation | $20.93 | 2023 | Opzelura |
| Biofrontera INC. | $20.71 | 2022 | |
| Allergan, INC. | $15.29 | 2020 | |
| Halozyme INC | $13.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Medling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.